• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Medical Aesthetics Market

    ID: MRFR/HC/11121-HCR
    128 Pages
    Rahul Gotadki
    October 2025

    US Medical Aesthetics Market Research Report Information By Product (Facial Aesthetic Products, Cosmetics Implant, Skin Aesthetic Devices, Body Contouring Devices, Physician-dispensed Cosmeceuticals and Skin Lighteners, Hair Removal Devices, Tattoo Removal Devices, Thread Lift Products, Physician-dispensed Eyelash Products, and Nail Treatment Laser Devices), By Procedure (Surgical Procedures (Breast Augmentation, Rhinoplasty, Facelift and Body Lift, Other Surgical Procedures), and Non-Surgical Procedures (Anti-Aging and Skin Rejuvenation, Ta...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Medical Aesthetics Market Infographic
    Purchase Options

    US Medical Aesthetics Market Summary

    The US Medical Aesthetics market is projected to grow significantly from 2.91 billion USD in 2024 to 7.21 billion USD by 2035.

    Key Market Trends & Highlights

    US Medical Aesthetics Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 7.81 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 6.65 billion USD, indicating robust growth potential.
    • In 2024, the market is valued at 2.91 billion USD, reflecting a strong foundation for future expansion.
    • Growing adoption of advanced aesthetic technologies due to increasing consumer demand for non-invasive procedures is a major market driver.

    Market Size & Forecast

    2024 Market Size 2.94 (USD Billion)
    2035 Market Size 7.21 (USD Billion)
    CAGR (2025-2035) 8.50%

    Major Players

    AbbVie, Cynosure, Evolus Inc., Revance Therapeutics, Inc, Galderma, Lumenis, Solta Medical, Syneron Candela, Alma Laser

    US Medical Aesthetics Market Trends

    Increase in the popularity of non-invasive and minimally invasive cosmetic procedures is driving the market growth

    Cosmetic medicine is seeing an increase in minimally invasive and non-surgical aesthetic procedures, which provide a practical and less dangerous substitute for conventional surgery. These procedures, which include chemical peels, microdermabrasion, laser therapy, dermal fillers, and Botox, address a variety of aesthetic issues with outcomes that seem natural. Their simplicity in recuperation and easy resumption of everyday activities stems from their minimal downtime. Furthermore, their adaptability and configurable features are making them more and more popular with people of all ages.

    For example, the Plastic Surgery Statistics Report 2020 from the American Society of Plastic Surgeons states that 6.8 million reconstructive treatments, 13.2 million cosmetic minimally invasive procedures, and 2.3 million cosmetic surgical procedures were carried out in the US in 2020. Significantly, these therapies reduce scarring, which makes them the therapy of choice for people who are worried about surgical scars. For safe and successful results, nevertheless, only licensed medical professionals should carry out these procedures, and for individualized treatment regimens, communication with healthcare providers is essential.

    Plastic surgery, breast implants, injection therapy for botulinum toxin, and other anti-aging goods and treatments have been made possible by technological advancements and large investments in research and development. The potential for growth in the anti-aging market has been increased by producers introducing safer and more effective treatments due to strict rules and regulations. Furthermore, specialized businesses have made high-end anti-aging products more accessible and available, despite the fact that department stores have always carried them. These days, these goods are sold through speciality retail stores, infomercials, home shopping channels, salons, spas, and internet sellers.

    Thus, driving the US Medical Aesthetics Market revenue.

    Market Segment Insights

    US Medical Aesthetics Product Insights

    The US Medical Aesthetics Market segmentation, based on product includes Facial Aesthetic Products, Cosmetics Implant, Skin Aesthetic Devices, Body Contouring Devices, Physician-dispensed Cosmeceuticals and Skin Lighteners, Hair Removal Devices, Tattoo Removal Devices, Thread Lift Products, Physical-Dispensed Eyelash Products, and Nail Treatment Laser Devices. The facial aesthetic products segment dominated the market mostly because more and more women are choosing to work, having more money to spend, and wanting to look young, attractive, and get the best possible treatment.

    Additionally, the segment's growth is expected to be influenced by the growing demand for derma filers because of their advantageous applications, which include reducing the look of sunken scars, softening facial creases and wrinkles, boosting shallow contours, and plumping thin lips.

    US Medical Aesthetics Procedure Insights

    The US Medical Aesthetics Market segmentation, based on procedure, includes Surgical Procedures (Breast Augmentation, Rhinoplasty, Facelift and Body Lift, Other Surgical Procedures), and Non-Surgical Procedures (Anti-Aging and Skin Rejuvenation, Tattoo and Scar Removal, Hair Removal, Lipolysis, and Other Non-Surgical Procedures. The non-surgical procedures category generated the most income. Some of the elements that have increased demand for non-invasive procedures include less pain, quick outcomes, and low cost. Nutraceuticals, soft tissue fillers, and chemical peels are popular non-invasive procedures.

    US Medical Aesthetics End User Insights

    The US Medical Aesthetics Market segmentation, based on end user, includes Clinics, Hospitals, and Medical Spas, Beauty Centers, and Home Care Settings. The clinics, hospitals, and medical spas category generated the most income because of a variety of factors, including the easier availability to material and financial resources at clinics and hospitals, including skilled surgeons and more. Furthermore, developments in medical aesthetic procedures are readily available and deliverable in hospitals and clinics, which supports segment expansion.

    Figure 1: US Medical Aesthetics Market, by End User, 2022 & 2032 (USD Billion)

    Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Get more detailed insights about US Medical Aesthetics Market

    Regional Insights

    The US Medical Aesthetics Market area will grow at a significant rate as a result of the large number of cosmetic procedures carried out, the aging population, more disposable income, greater awareness, and government support for the infrastructure of healthcare. The region's robust research pipeline, the development of high-tech products, and the FDA's approval of aesthetic devices for home use are all contributing factors to the growing demand for US Medical Aesthetics. Additionally, a variety of market participants in this nation contribute to the industry's growth.

    The market is expected to grow even faster as long as major players in the country continue to meet the high and rising demand.

    Key Players and Competitive Insights

    Leading market players are investing heavily in research and development in order to expand their product lines, which will help the US Medical Aesthetics Market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their  footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, US Medical Aesthetics industry must offer cost-effective items.

    Key Companies in the US Medical Aesthetics Market market include

    Industry Developments

    • Q2 2024: Allergan Aesthetics Announces FDA Approval of Skinvive™ by JUVÉDERM® for the Improvement of Cheek Skin Smoothness in Adults Allergan Aesthetics, an AbbVie company, received FDA approval for Skinvive™ by JUVÉDERM®, a hyaluronic acid intradermal microdroplet injection, for improving cheek skin smoothness in adults.
    • Q2 2024: Crown Aesthetics Announces FDA Clearance of SkinPen® Precision for the Treatment of Neck Wrinkles Crown Aesthetics received FDA clearance for its SkinPen® Precision microneedling device to treat neck wrinkles, expanding its indications beyond facial acne scars.
    • Q2 2024: Soliton Announces FDA Clearance of Rapid Acoustic Pulse Device for Cellulite Reduction Soliton, Inc. received FDA clearance for its Rapid Acoustic Pulse device, designed for the reduction in the appearance of cellulite, marking a new product entry in the U.S. medical aesthetics market.
    • Q3 2024: Alma Lasers Launches Alma TED™ Hair Restoration System in the United States Alma Lasers announced the U.S. launch of Alma TED™, a non-invasive ultrasound-based system for hair restoration, expanding its portfolio of energy-based aesthetic devices.
    • Q3 2024: Galderma Announces U.S. Launch of Restylane® Eyelight™ for the Treatment of Undereye Hollows Galderma launched Restylane® Eyelight™ in the U.S., a hyaluronic acid dermal filler specifically indicated for the treatment of undereye hollows.
    • Q3 2024: Sientra Files for Chapter 11 Bankruptcy Protection Sientra, a U.S. medical aesthetics company specializing in breast implants and body contouring, filed for Chapter 11 bankruptcy protection as it seeks to restructure its operations.
    • Q4 2024: Revance Therapeutics Announces FDA Approval of DAXXIFY® for the Treatment of Cervical Dystonia Revance Therapeutics received FDA approval for DAXXIFY® (daxibotulinumtoxinA-lanm) for the treatment of cervical dystonia, expanding its therapeutic indications in the U.S. market.
    • Q4 2024: Merz Aesthetics Launches Radiesse® (+) Lidocaine for Hand Augmentation in the U.S. Merz Aesthetics announced the U.S. launch of Radiesse® (+) Lidocaine, a dermal filler for hand augmentation to correct volume loss in the dorsum of the hands.
    • Q1 2025: Cutera Appoints New CEO to Lead Next Phase of Growth Cutera, a provider of energy-based aesthetic systems, appointed a new Chief Executive Officer to drive the company’s strategic growth initiatives in the U.S. medical aesthetics sector.
    • Q1 2025: Venus Concept Announces U.S. Launch of Venus Bliss Max™ for Non-Invasive Body Contouring Venus Concept launched Venus Bliss Max™ in the U.S., a new non-invasive device for body contouring and fat reduction, expanding its product offerings in the medical aesthetics market.
    • Q2 2025: Almirall Completes Acquisition of Bonti, Expanding U.S. Aesthetics Portfolio Almirall completed the acquisition of Bonti, a U.S.-based company focused on fast-acting neurotoxin treatments, strengthening its position in the U.S. medical aesthetics market.
    • Q2 2025: Cynosure Announces Opening of New U.S. Manufacturing Facility for Aesthetic Devices Cynosure opened a new manufacturing facility in the United States to increase production capacity for its portfolio of energy-based aesthetic devices.

    Future Outlook

    US Medical Aesthetics Market Future Outlook

    Market Segmentation

    US Medical Aesthetics Product Outlook

    • Facial Aesthetic Products
    • Cosmetics Implant
    • Skin Aesthetic Devices
    • Body Contouring Devices
    • Physician-dispensed Cosmeceuticals and Skin Lighteners
    • Hair Removal Devices
    • Tattoo Removal Devices
    • Thread Lift Products
    • Physician-dispensed Eyelash Products
    • Nail Treatment Laser Devices

    US Medical Aesthetics End User Outlook

    • Clinics
    • Hospitals
    • and Medical Spas
    • Beauty Centers
    • Home Care Settings
    • Q2 2024: Allergan Aesthetics Announces FDA Approval of Skinvive™ by JUVÉDERM® for the Improvement of Cheek Skin Smoothness in Adults Allergan Aesthetics
    • an AbbVie company
    • received FDA approval for Skinvive™ by JUVÉDERM®
    • a hyaluronic acid intradermal microdroplet injection
    • for improving cheek skin smoothness in adults.
    • Q2 2024: Crown Aesthetics Announces FDA Clearance of SkinPen® Precision for the Treatment of Neck Wrinkles Crown Aesthetics received FDA clearance for its SkinPen® Precision microneedling device to treat neck wrinkles
    • expanding its indications beyond facial acne scars.
    • Q2 2024: Soliton Announces FDA Clearance of Rapid Acoustic Pulse Device for Cellulite Reduction Soliton
    • Inc. received FDA clearance for its Rapid Acoustic Pulse device
    • designed for the reduction in the appearance of cellulite
    • marking a new product entry in the U.S. medical aesthetics market.
    • Q3 2024: Alma Lasers Launches Alma TED™ Hair Restoration System in the United States Alma Lasers announced the U.S. launch of Alma TED™
    • a non-invasive ultrasound-based system for hair restoration
    • expanding its portfolio of energy-based aesthetic devices.
    • Q3 2024: Galderma Announces U.S. Launch of Restylane® Eyelight™ for the Treatment of Undereye Hollows Galderma launched Restylane® Eyelight™ in the U.S.
    • a hyaluronic acid dermal filler specifically indicated for the treatment of undereye hollows.
    • Q3 2024: Sientra Files for Chapter 11 Bankruptcy Protection Sientra
    • a U.S. medical aesthetics company specializing in breast implants and body contouring
    • filed for Chapter 11 bankruptcy protection as it seeks to restructure its operations.
    • Q4 2024: Revance Therapeutics Announces FDA Approval of DAXXIFY® for the Treatment of Cervical Dystonia Revance Therapeutics received FDA approval for DAXXIFY® (daxibotulinumtoxinA-lanm) for the treatment of cervical dystonia
    • expanding its therapeutic indications in the U.S. market.
    • Q4 2024: Merz Aesthetics Launches Radiesse® (+) Lidocaine for Hand Augmentation in the U.S. Merz Aesthetics announced the U.S. launch of Radiesse® (+) Lidocaine
    • a dermal filler for hand augmentation to correct volume loss in the dorsum of the hands.
    • Q1 2025: Cutera Appoints New CEO to Lead Next Phase of Growth Cutera
    • a provider of energy-based aesthetic systems
    • appointed a new Chief Executive Officer to drive the company’s strategic growth initiatives in the U.S. medical aesthetics sector.
    • Q1 2025: Venus Concept Announces U.S. Launch of Venus Bliss Max™ for Non-Invasive Body Contouring Venus Concept launched Venus Bliss Max™ in the U.S.
    • a new non-invasive device for body contouring and fat reduction
    • expanding its product offerings in the medical aesthetics market.
    • Q2 2025: Almirall Completes Acquisition of Bonti
    • Expanding U.S. Aesthetics Portfolio Almirall completed the acquisition of Bonti
    • a U.S.-based company focused on fast-acting neurotoxin treatments
    • strengthening its position in the U.S. medical aesthetics market.
    • Q2 2025: Cynosure Announces Opening of New U.S. Manufacturing Facility for Aesthetic Devices Cynosure opened a new manufacturing facility in the United States to increase production capacity for its portfolio of energy-based aesthetic devices.

    US Medical Aesthetics Procedure Outlook

    • {""=>["Breast Augmentation"
    • "Rhinoplasty"
    • "Facelift and Body Lift"
    • "Other Surgical Procedures"]}
    • {""=>["Anti-Aging and Skin Rejuvenation"
    • "Tattoo and Scar Removal"
    • "Hair Removal"
    • "Lipolysis"
    • "Other Non-Surgical Procedures"]}

    Report Scope

    Report Attribute/MetricDetails
    Market Size 20357.21 (Value (USD Billion))
    Compound Annual Growth Rate (CAGR)8.50% (2025 - 2035)
    Base Year2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2023
    Market Forecast UnitsValue (USD Billion)
    Report CoverageRevenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments CoveredProduct, Procedure, End User, and Region
    Countries CoveredUS
    Key Companies ProfiledAbbVie; Cynosure; Evolus Inc.; Revance Therapeutics, Inc; Galderma; Lumenis; Solta Medical; Syneron Candela; Alma Laser
    Key Market Opportunities·       Growing incidence of obesity and heightened awareness of cosmetic procedures
    Key Market Dynamics·       Increase in the number of cosmetic procedures that are non-invasive and low invasive
    Market Size 20242.94 (Value (USD Billion))
    Market Size 20253.19 (Value (USD Billion))

    FAQs

    What is the projected growth of the US Medical Aesthetics market?

    The US Medical Aesthetics market is the expected increase in total market value of 7.21 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the US Medical Aesthetics market?

    US Medical Aesthetics market size was valued at approximately 2.94 billion USD in 2024. This figure will reach 7.21 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the US Medical Aesthetics market?

    US Medical Aesthetics market is expected to grow at a CAGR of 8.5% between 2025 and 2035.

    How much will the US Medical Aesthetics market be worth by 2035?

    US Medical Aesthetics market is expected to be worth of 7.21 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the US Medical Aesthetics market perform over the next 10 years?

    Over the next 10 years the US Medical Aesthetics market is expected to shift from usd billion 2.94 to 7.21 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials